In silico molecular docking and molecular dynamic simulation of potential inhibitors of 3C-like main proteinase (3CLpro) from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) using selected african medicinal plants

被引:0
|
作者
Mustafa Alhaji Isa
Adam Mustapha
Sahar Qazi
Khalid Raza
Ibrahim Alkali Allamin
Muhammad M. Ibrahim
Mohammed M. Mohammed
机构
[1] University of Maiduguri,Department of Microbiology, Faculty of Science
[2] Jamia Millia Islamia,Department of Computer Science
来源
关键词
In silico; Molecular docking; SARS-CoV-2; Pharmacokinetic; Physicochemical; MD simulation;
D O I
暂无
中图分类号
学科分类号
摘要
The Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) is an infectious virus that causes mild to severe life-threatening upper respiratory tract infection. The virus emerged in Wuhan, China in 2019, and later spread across the globe. Its genome has been completely sequenced and based on the genomic information, the virus possessed 3C-Like Main Protease (3CLpro), an essential multifunctional enzyme that plays a vital role in the replication and transcription of the virus by cleaving polyprotein at eleven various sites to produce different non-structural proteins. This makes the protein an important target for drug design and discovery. Herein, we analyzed the interaction between the 3CLpro and potential inhibitory compounds identified from the extracts of Zingiber offinale and Anacardium occidentale using in silico docking and Molecular Dynamics (MD) Simulation. The crystal structure of SARS-CoV-2 main protease in complex with 02J (5-Methylisoxazole-3-carboxylic acid) and PEJ (composite ligand) (PDB Code: 6LU7, 2.16 Å) retrieved from Protein Data Bank (PDB) and subject to structure optimization and energy minimization. A total of twenty-nine compounds were obtained from the extracts of Z. offinale and the leaves of A. occidentale. These compounds were screened for physicochemical (Lipinski rule of five, Veber rule, and Egan filter), Pan-Assay Interference Structure, and pharmacokinetic properties to determine the Pharmaceutical Active Ingredients. Of the 29 compounds, only nineteen (19) possessed drug-likeness properties with efficient oral bioavailability and less toxicity. These compounds subjected to molecular docking analysis to determine their binding energies with the 3CLpro. The result of the analysis indicated that the free binding energies of the compounds ranged between − 5.08 and − 10.24 kcal/mol, better than the binding energies of 02j (− 4.10 kcal/mol) and PJE (− 5.07 kcal/mol). Six compounds (CID_99615 = − 10.24 kcal/mol, CID_3981360 = 9.75 kcal/mol, CID_9910474 = − 9.14 kcal/mol, CID_11697907 = − 9.10 kcal/mol, CID_10503282 = − 9.09 kcal/mol and CID_620012 = − 8.53 kcal/mol) with good binding energies further selected and subjected to MD Simulation to determine the stability of the protein–ligand complex. The results of the analysis indicated that all the ligands form stable complexes with the protein, although, CID_9910474 and CID_10503282 had a better stability when compared to other selected phytochemicals (CID_99615, CID_3981360, CID_620012, and CID_11697907).
引用
收藏
页码:107 / 123
页数:16
相关论文
共 50 条
  • [1] In silico molecular docking and molecular dynamic simulation of potential inhibitors of 3C-like main proteinase (3CLpro) from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) using selected african medicinal plants
    Isa, Mustafa Alhaji
    Mustapha, Adam
    Qazi, Sahar
    Raza, Khalid
    Allamin, Ibrahim Alkali
    Ibrahim, Muhammad M.
    Mohammed, Mohammed M.
    ADVANCES IN TRADITIONAL MEDICINE, 2022, 22 (01) : 107 - 123
  • [2] In Silico Molecular Docking and Molecular Dynamic Simulation Analysis of Phytochemicals From Indian Foods as Potential Inhibitors of SARS-CoV-2 RdRp and 3CLpro
    Qazi, Sahar
    Das, Soumi
    Khuntia, Bharat Krushna
    Sharma, Vandna
    Sharma, Shruti
    Sharma, Gautam
    Raza, Khalid
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (09)
  • [3] Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
    Ibrahim, Mahmoud A. A.
    Abdelrahman, Alaa H. M.
    Mohamed, Dina E. M.
    Abdeljawaad, Khlood A. A.
    Naeem, Mohamed Ahmed
    Gabr, Gamal A.
    Shawky, Ahmed M.
    Soliman, Mahmoud E. S.
    Sidhom, Peter A.
    Pare, Paul W.
    Hegazy, Mohamed-Elamir F.
    VIRUSES-BASEL, 2023, 15 (01):
  • [4] Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations
    Mosquera-Yuqui, Francisco
    Lopez-Guerra, Nicolas
    Moncayo-Palacio, Eduardo A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (05): : 2010 - 2023
  • [5] Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020
    Chen, Roufen
    Gao, Yali
    Liu, Han
    Li, He
    Chen, Wenfa
    Ma, Junjie
    RSC MEDICINAL CHEMISTRY, 2023, 14 (01): : 9 - 21
  • [6] In silico studies of natural products from medicinal plants to identify potential inhibitors for SARS-CoV-2 3C-like protease
    Nguyen Tan Khanh
    Tran Thanh Hoa
    VIETNAM JOURNAL OF CHEMISTRY, 2021, 59 (05) : 557 - 562
  • [7] Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies
    Saquib, Quaiser
    Bakheit, Ahmed H.
    Ahmed, Sarfaraz
    Ansari, Sabiha M.
    Al-Salem, Abdullah M.
    Al-Khedhairy, Abdulaziz A.
    MOLECULES, 2024, 29 (05):
  • [8] Identification of phytochemical inhibitors of SARS-CoV-2 protease 3CLpro from selected medicinal plants as per molecular docking, bond energies and amino acid binding energies
    Ullah, Sami
    Munir, Bushra
    Al-Sehemi, Abdullah G.
    Muhammad, Shabbir
    Haq, Ikram-Ul
    Aziz, Abida
    Ahmed, Bilal
    Ghaffar, Abdul
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (06)
  • [9] In silico and in vitro assays reveal potential inhibitors against 3CLpro main protease of SARS-CoV-2
    Iype, Eldhose
    Jisha, Pillai U.
    Kumar, Indresh
    Gaastra-Nedea, Silvia V.
    Subramanian, Ramachandran
    Saha, Ranendra Narayan
    Dutta, Mainak
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23): : 12800 - 12811
  • [10] Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches
    Ahmadi, Shahrzad
    Bazargan, Mahsa
    Elahi, Reza
    Esmaeilzadeh, Abdolreza
    MOLECULAR IMMUNOLOGY, 2023, 156 : 10 - 19